0001847903-24-000031.txt : 20240202
0001847903-24-000031.hdr.sgml : 20240202
20240202170352
ACCESSION NUMBER: 0001847903-24-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rotman Harris
CENTRAL INDEX KEY: 0001981420
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40445
FILM NUMBER: 24592550
MAIL ADDRESS:
STREET 1: C/O CENTESSA PHARMACEUTICALS PLC
STREET 2: 3RD FL., 1 ASHLEY RD, ALTRINCHAM
CITY: CHESHIRE
STATE: X0
ZIP: WA14 2DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Centessa Pharmaceuticals plc
CENTRAL INDEX KEY: 0001847903
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3RD FLOOR
STREET 2: 1 ASHLEY ROAD
CITY: ALTRINCHAM, CHESHIRE
STATE: X0
ZIP: WA14 2DT
BUSINESS PHONE: 44 7391 789784
MAIL ADDRESS:
STREET 1: 3RD FLOOR
STREET 2: 1 ASHLEY ROAD
CITY: ALTRINCHAM, CHESHIRE
STATE: X0
ZIP: WA14 2DT
FORMER COMPANY:
FORMER CONFORMED NAME: Centessa Pharmaceuticals Ltd
DATE OF NAME CHANGE: 20210224
4
1
wk-form4_1706911412.xml
FORM 4
X0508
4
2024-02-01
0
0001847903
Centessa Pharmaceuticals plc
CNTA
0001981420
Rotman Harris
C/O CENTESSA PHARMACEUTICALS PLC
3RD FL., 1 ASHLEY RD, ALTRINCHAM
CHESHIRE
X0
WA14 2DT
UNITED KINGDOM
0
1
0
0
SVP Regulatory Affairs
1
Ordinary Shares
2024-02-01
4
A
0
37500
0
A
71000
D
Ordinary Shares
2024-02-01
4
F
0
4108
8.19
D
66892
D
Ordinary Shares
2024-02-01
4
S
0
4267
8.1027
D
62625
D
Share Option (right to buy)
8.01
2024-02-01
4
A
0
75000
0
A
2034-02-01
Ordinary Shares
75000
75000
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 1, 2025.
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.83 to $8.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.
/s/ Gregory Weinhoff, attorney-in-fact
2024-02-02